High t-PA antigen concentrations usually mean low t-PA activity The apparent paradox is to some extent resolved by consideration of the relation between t-PA and PAI-I concentrations and t-PA activity. t-PA forms a stochiometric 1:1 molecular complex with PAI-I that is inactive and is cleared from the circulation, probably by interacting with hepatic receptors. In population studies, there is an approximately linear relation between t-PA and PAI-1 plasma concentrations; the equilibrium of the reaction is such that high t-PA (and higher PAI-i) antigen concentrations are associated with low t-PA activity and vice versa. Thus, to a first approximation, high plasma t-PA antigen concentration is a marker for high PAI-i concentrations and low intrinsic thrombolytic activity. This has now been shown in several studies in patients with ischaemic heart disease68 and diabetes.9 One of the most meticulous of these studies, at least from the point of haemostatic risk factors, was the ECAT (European concerted action on thrombosis and disabilities) study that examined these risk factors in 3000 patients undergoing coronary angiography for angina pectoris. Patients with one or more coronary stenoses had higher plasma PAI antigen and PAI activity levels, higher t-PA antigen before (but not after) venous occlusion, and longer euglobulin clot lysis times. There was a trend towards lower t-PA activity in patients with coronary disease. This finding also accords with the observation of a significant association between low fibrinolytic activity (measured by dilute blood clot lysis time) and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.'0 Control of t-PA and PAI-1 production Though recognition that high basal t-PA antigen concentrations in plasma are usually associated with low t-PA activities provides at least a partial explanation for the epidemiological studies, there is still much we do not know about the dynamic balance between t-PA and PAI-1 activity and its control.
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The ability of vascular tissues to induce fibrinolysis has long been recognised, and both t-PA and its mRNA can be identified in endothelial cell cultures. However, t-PA production by such cultures varies considerably with culture conditions, and possibly also with species. In situ bovine aortic endothelium produces principally t-PA mRNA and very small amounts of PAI-1, PAI-2, and urokinase (u-PA) mRNA. In culture, the same endothelium produces substantial amounts of all these mRNA species."
Basal production of t-PA by cultured human umbilical endothelium is low, though it can be up regulated by various stimuli; whereas cultured endothelial cells tend to 
